Behavioural science and the Covid-19 pandemic
On Thursday 12th March 2020, the prime minister of the UK gave a speech outlining the strategy for delaying the Covid-19 pandemic[1]. In...
Contributors
-
Joint Head of Behavioural Science -
Account Manager -
-
Associate Consultant -
Joint Head of Behavioural Science -
President, USA -
Vice President, Business Development -
Senior Consultant -
-
Publications Executive -
Project Director -
-
Strategic Communications Director -
Associate Consultant -
Executive Chairman -
Consultant -
-
CEO -
-
Senior Consultant -
Consultant -
Senior Consultant -
SVP -
Master Practitioner: Patient Insights -
Publications Assistant -
EVP, Oncology Practice Head -
EVP, Patient Solutions -
-
US CEO -
-
Associate Editorial Director
-
Sr. Research Analyst -
-
Principal -
Research Executive -
Account Director -
-
-
Head of MedErgy (CH-MedErgy) -
-
Managing Consultant -
Project Manager -
Project Director -
Executive Vice President, Strategic Collaborations -
Associate Consultant
Cello Health Archive
- July 2021 (2)
- April 2021 (3)
- March 2021 (4)
- January 2021 (1)
- December 2020 (1)
- November 2020 (1)
- October 2020 (2)
- September 2020 (3)
- August 2020 (6)
- July 2020 (3)
- June 2020 (1)
- May 2020 (1)
- April 2020 (2)
- March 2020 (6)
- February 2020 (19)
- January 2020 (4)
- December 2019 (3)
- November 2019 (4)
- October 2019 (1)
- September 2019 (2)
- August 2019 (4)
- July 2019 (4)
- June 2019 (4)
- May 2019 (12)
- April 2019 (11)
- March 2019 (5)
- February 2019 (12)
- January 2019 (1)
- October 2018 (2)
- August 2018 (5)
- July 2018 (7)
- June 2018 (5)
- May 2018 (5)
- April 2018 (6)
- March 2018 (9)
- February 2018 (11)
- January 2018 (4)
- December 2017 (8)
- November 2017 (21)
- October 2017 (35)
- September 2017 (18)
- August 2017 (1)
- July 2017 (1)
- June 2017 (1)
- May 2017 (2)
- April 2017 (2)
- March 2017 (1)
- February 2017 (2)
- January 2017 (1)
- December 2016 (1)
- October 2016 (1)
Is Novartis’ RNA Therapeutic Inclisiran Poised to Displace PCSK9 Antibodies and Become the Next Blockbuster Lipid-Lowering Drug?
In the last several years, RNA-targeted platforms yielded FDA/EMA approved therapies for ultra-rare metabolic and neurodegenerative...
COVID-19 – BIOTECH DISRUPTION OR DEVASTATION?
Dominating news headlines around the world, the COVID-19 pandemic is asking multiple questions that challenge current norms within every...
Why is Market Research important?
Market research is the foundation of success for any business venture. It’s the process of systematically collecting and analysing an...
“Plans Are Worthless, But Planning Is Everything” - Biotech leaders discuss key challenges in self-commercialization for late-stage assets
In early February, Cello Health Consulting’s Carl Engleman moderated a panel discussion with senior biotech leaders at the LSX World...
Cello Health BioConsulting's Next Insight Series Webinar- The Emerging Role of Nucleic Acid Therapeutics: Resuscitating Cardiovascular Drug Development with Disruptive Therapies
Over the past several years, small biotech led significant progress in the development and clinical validation of nucleic acid...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net